Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Clinical Landscape and Prognostic Impact of Extramedullary Disease in Multiple Myeloma: A Large Single-Center Retrospective Analysis

MM - 1322

Clinical Landscape and Prognostic Impact of Extramedullary Disease in Multiple Myeloma: A Large Single-Center Retrospective Analysis

Rahal Amira

Poster Presenter: Rahal Amira

Thumbnail for Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

CLL - 868

Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko

Previous 1...19 20 21 22 23 24 25...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for Clinical Outcomes Among Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Zanubrutinib or Acalabrutinib in Real-World Practice in the United States$

MCL - 178

Clinical Outcomes Among Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Zanubrutinib or Acalabrutinib in Real-World Practice in the United States

Javier Munoz

Poster Presenter: Javier Munoz

Thumbnail for Clinical Outcomes and Measurable Residual Disease in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

CLL - 1216

Clinical Outcomes and Measurable Residual Disease in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

Aizaz Anwar Khalid

Poster Presenter: Aizaz Anwar Khalid

Thumbnail for Clinical Outcomes and Predictors of Early Inpatient CAR-T Administration Within 48 Hours: A Nationwide Analysis

CLL - 119

Clinical Outcomes and Predictors of Early Inpatient CAR-T Administration Within 48 Hours: A Nationwide Analysis

Fiqe Khan

Poster Presenter: Fiqe Khan

$Thumbnail for Clinical Outcomes and Safety Profile of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

CT - 989

Clinical Outcomes and Safety Profile of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Momna Nisar

Poster Presenter: Momna Nisar

Thumbnail for Clinical Outcomes Following Ibrutinib Withdrawal in Mantle Cell Lymphoma: A TriNetX Analysis

MCL - 1233

Clinical Outcomes Following Ibrutinib Withdrawal in Mantle Cell Lymphoma: A TriNetX Analysis

Kumar Anmol

Poster Presenter: Kumar Anmol

$Thumbnail for Clinical Outcomes in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R B-ALL) Who Achieved Remission Following Treatment with Obecabtagene autoleucel (obe-cel) in the FELIX Study$

ALL - 706

Clinical Outcomes in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R B-ALL) Who Achieved Remission Following Treatment with Obecabtagene autoleucel (obe-cel) in the FELIX Study

Elias Jabbour

Poster Presenter: Elias Jabbour

$Thumbnail for Clinical Outcomes of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin Lymphoma in a Resource-Limited Setting$

HL - 962

Clinical Outcomes of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin Lymphoma in a Resource-Limited Setting

Hammad Javed

Poster Presenter: Hammad Javed

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors